Sector Update: Healthcare Shares Flat to Higher; Cleveland BioLabs Cuts Net Loss in Half Year-Over-Year

By
A A A

Top Healthcare Stocks:

JNJ: +0.16%

PFE: +0.10%

ABT: flat

MRK: flat

AMGN: flat

Healthcare shares are flat to higher in pre-market trade. Cleveland BioLabs ( CBLI ), a biotechnology company focused on oncology, reported that its Q2 net loss halved to $0.07 from $0.14 a year earlier.

Revenue for the second quarter of 2013 increased to $1.6 million, compared to $0.3 million for the prior year's second quarter. The stock closed at $1.70 Monday in a 52-week range of $1.23 - $2.95.

And, Covidien ( COV ), which makes healthcare products, said it has expanded its radiofrequency catheter range with the launch of a new line to treat Barrett's esophagus and some gastrointestinal disorders.

The product is called the Barrx Channel RFA Endoscopic Catheter. Covidien is unchanged pre-market and is trading close to the top of its 52-week range of $47.31 - $64.10.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: CBLI , COV

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

100%
67%

Most Active by Volume

65,878,391
  • $102.25 ▲ 0.12%
60,267,006
  • $16.01 ▼ 1.17%
45,656,511
  • $13.11 ▼ 4.17%
34,766,553
  • $49.43 ▲ 2.85%
34,661,727
  • $3.60 ▲ 0.28%
29,041,259
  • $19.12 ▼ 0.47%
21,343,464
  • $73.855 ▼ 1.04%
19,552,720
  • $10.85 ▼ 3.13%
As of 8/28/2014, 04:03 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com